Company Curasight A/S

Equities

CURAS

DK0061295797

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Chiffre d''affaires - Rate of surprise

Sector Other Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-04-17 pm EDT			5-day change	1st Jan Change
10.05 ^DKK	-0.99%		+3.61%	-43.38%

Apr. 16	Curasight A/S Announces Approval of Clinical Trial Application for Phase 2 Trial with uTRACE in Prostate Cancer Patients	CI
Apr. 12	Curasight A/S Announces Board Changes	CI

Curasight A/S is a clinical development company based in Copenhagen, Denmark. The Company is a pioneer in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). The technology provides improved diagnosis and risk stratification in multiple cancer types.

Number of employees: 4

Managers	Title	Age	Since
Carsten Nielsen FOU	Founder	41	12-12-31
Jacob Madsen FOU	Founder	52	12-12-31
Andreas Kjaer FOU	Founder	61	12-12-31
Ulrich Krasilnikoff CEO	Chief Executive Officer	57	15-12-31
Hanne Damgaard Jensen COO	Chief Operating Officer	-	21-12-31
Nic Gillings LAW	General Counsel	56	-

Members of the board	Title	Age	Since
Kirsten Drejer BRD	Director/Board Member	68	21-05-03
Per Falholt CHM	Chairman	65	19-12-31
Ulrich Krasilnikoff CEO	Chief Executive Officer	57	15-12-31
Lars Trolle BRD	Director/Board Member	57	13-12-31
Andreas Kjaer FOU	Founder	61	12-12-31
Charlotte Vedel BRD	Director/Board Member	56	19-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	19,893,891	16,955,077 ( 85.23 %)	0	85.23 %

Name	Equities	%	Valuation
Andreas Kjaer 30.24 %	6,015,912	30.24 %	10 M kr
UK Curacap ApS 20.01 %	3,980,767	20.01 %	6 M kr
Carsten Nielsen 12.11 %	2,409,150	12.11 %	4 M kr
Jacob Madsen 4.570 %	909,151	4.570 %	1 M kr
Lars Trolle 2.950 %	586,869	2.950 %	927 998 kr
Per Falholt 0.3300 %	65,650	0.3300 %	103 810 kr
Charlotte Vedel 0.2000 %	39,788	0.2000 %	62 916 kr
Kirsten Drejer 0.0200 %	3,979	0.0200 %	6 292 kr
Hanne Damgaard Jensen 0.0200 %	3,979	0.0200 %	6 292 kr
AIFM Capital AB 0.000000 %	0	0.000000 %	- kr

Curasight A/S

Ole Maaløes Vej 3

2200, Copenhagen

+45 22 83 01 60

http://www.curasight.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
CURASIGHT A/S	-43.38%	28.79M
IQVIA HOLDINGS INC.	-1.82%	41.36B
LONZA GROUP AG	+44.25%	41.3B
MODERNA, INC.	+2.56%	39.61B
CELLTRION, INC.	-12.11%	25.62B
ICON PUBLIC LIMITED COMPANY	+3.09%	24.09B
ALNYLAM PHARMACEUTICALS, INC.	-24.16%	18.38B
MEDPACE HOLDINGS, INC.	+22.12%	11.85B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.74%	11.82B
UNITED THERAPEUTICS CORPORATION	+7.75%	11.07B

Other Biotechnology & Medical Research